Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by White Christopher G, Directeur commercial. Insider active across 2 companies, notably OCULAR THERAPEUTIX, INC. In total, 5 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €46k. Activity tracked since 3 February 2022. The latest transaction was filed on 3 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Christopher G. White is the Chief Business Officer at Ocular Therapeutix, Inc. He is responsible for business strategy and development. His experience in the biopharmaceutical sector is an asset in guiding Ocular Therapeutix in its growth initiatives.